Active — Not RecruitingNot Applicable

Novosyn® Quick in Patients Undergoing Episiotomy Closure

Spain229 participantsStarted 2024-05-09

Plain-language summary

Retrospective, monocentric clinical study on the clinical performance of Novosyn® Quick in patients undergoing episiotomy closure.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Women who underwent an indicated episiotomy between January 2020 - December 2020 at the Hospital General de Catalunya (Sant Cugat del Vallès, Spain) and received Novosyn® Quick Exclusion Criteria: * No exclusion criteria have been set

What they're measuring

Wound dehiscence rate

Timeframe: up to 1 month postpartum

Trial details

NCT IDNCT05233527

SponsorAesculap AG

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2026-03-26

View on ClinicalTrials.gov More Episiotomy Wound trials